CA1108988A - Dosage de proteines d'origine virale pour le depistage du cancer - Google Patents

Dosage de proteines d'origine virale pour le depistage du cancer

Info

Publication number
CA1108988A
CA1108988A CA301,029A CA301029A CA1108988A CA 1108988 A CA1108988 A CA 1108988A CA 301029 A CA301029 A CA 301029A CA 1108988 A CA1108988 A CA 1108988A
Authority
CA
Canada
Prior art keywords
breast cancer
viral
rna
dna polymerase
human breast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA301,029A
Other languages
English (en)
Inventor
Sol Spiegelman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1108988A publication Critical patent/CA1108988A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA301,029A 1977-05-23 1978-04-13 Dosage de proteines d'origine virale pour le depistage du cancer Expired CA1108988A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79981077A 1977-05-23 1977-05-23
US799,810 1991-11-29

Publications (1)

Publication Number Publication Date
CA1108988A true CA1108988A (fr) 1981-09-15

Family

ID=25176811

Family Applications (1)

Application Number Title Priority Date Filing Date
CA301,029A Expired CA1108988A (fr) 1977-05-23 1978-04-13 Dosage de proteines d'origine virale pour le depistage du cancer

Country Status (3)

Country Link
JP (3) JPS53145913A (fr)
CA (1) CA1108988A (fr)
DE (1) DE2729893A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409200A (en) * 1980-04-28 1983-10-11 Research Corporation Reverse transcriptase from human milk, method for its purification, and its use in the detection of breast cancer
IL60987A0 (en) * 1980-09-05 1980-11-30 Uni Ramot & Ind Dev Ltd Detection of breast cancer
IE820942L (en) * 1982-04-21 1983-10-21 Bartos Patent Dev Holding Determining in-viro effectiveness of cytostatic agents
JPS6028278B2 (ja) * 1982-12-23 1985-07-03 家畜衛生試験場長 培養腫瘍細胞による逆転写酵素の生産法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755086A (en) * 1971-02-09 1973-08-28 Hoffmann La Roche Diagnostic method utilizing synthetic deoxyrilionucleotide oligomer template
US3859430A (en) * 1973-01-29 1975-01-07 Us Navy Radioactive iodine labeling of viruses, enzymes and flourescene isothyiocyanate
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer

Also Published As

Publication number Publication date
JPS61247383A (ja) 1986-11-04
JPS6215826B2 (fr) 1987-04-09
JPS53145913A (en) 1978-12-19
DE2729893A1 (de) 1978-11-30
JPS6327500A (ja) 1988-02-05

Similar Documents

Publication Publication Date Title
MELEWICZ et al. PERIPHERAL BLOOD MONOCYTES’
Tomasetto et al. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21. 3 region of chromosome 17
Strand et al. Type-C RNA virus gene expression in human tissue
US4379839A (en) Method for detecting cancer
Lee et al. A solid-phase fluorescent immunoassay for human prostatic acid phosphatase
Koffler et al. Antibodies to polynucleotides in human sera: antigenic specificity and relation to disease
US4146603A (en) Tumor specific glycoproteins and method for detecting tumorigenic cancers
Strand et al. Structural proteins of mammalian oncogenic RNA viruses: immunological characterization of the p15 polypeptide of Rauscher murine virus
Krakower et al. Radioimmunoassay for mammalian type C viral reverse transcriptase
US5068175A (en) Method of detecting ras oncogene related malignancies
Hollinshead et al. Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera
Bauer et al. An RNA-dependent DNA polymerase, different from the known viral reverse transcriptases, in the chicken system.
CA1108988A (fr) Dosage de proteines d'origine virale pour le depistage du cancer
Jacquemin et al. Antibody response in cats to feline leukemia virus reverse transcriptase under natural conditions of exposure to the virus
JPH05504476A (ja) ヒト胃癌検出用診断プローブ
Irie et al. Relation between the tumor-specific antigen and cytological characteristics in mouse mammary tumors
Jun et al. Establishment of immuno-PCR technique for the detection of tumor associated antigen MG 7-Ag on the gastric cancer cell line
Kimball et al. Characterization of mouse mammary tumor viruses from primary tumor cell cultures. II. Biochemical and biophysical studies
Sarin et al. Characterization of terminal deoxynucleotidyltransferase in a cell line (8402) derived from a patient with acute lymphoblastic leukemia
CA2215693A1 (fr) Proteine marqueur de tumeurs destinee a evaluer les risques de cancer
WO2004042401A1 (fr) Procede d'examen de cellules cancereuses et reactif associe
Chow et al. Identification of LDH–rasp21 Protein Complex and Expression of These Genes in Human Ovarian Cancer
Liautard Proteins of the polysomal messenger ribonucleoprotein are responsible for its association with the 40-S ribosomal subunit in HeLa cells
Kantor et al. DNA polymerase with characteristics of reverse transcriptase purified from human milk
Gambari et al. Lack of correlation between hypomethylation and expression of the HLA‐DRα gene

Legal Events

Date Code Title Description
MKEX Expiry